Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Thomas

Showing results (51-60 of 262) with videos related to

Pageof 27
Sort By:
Oncology and Therapy|March 30, 2024
Is There any Relationship Between the Repeated Complications of Sickle Cell Disease and the Potential Development of Acute Leukemia?Giovanna Cannas, Mohamed Elhamri, Xavier Thomas
Bulletin Du Cancer|August 26, 2011
[Novel conventional therapies in onco-hemathology]Frédéric Baleydier, Carine Domenech, Xavier Thomas
Expert Review of Hematology|April 21, 2020
Emerging pharmacotherapies for elderly acute myeloid leukemia patientsXavier Thomas, Mohamed Elhamri, Maël Heiblig
Bulletin Du Cancer|August 30, 2008
[Adult acute lymphoblastic leukemia with central nervous system involvement: an overview]Xavier Thomas, Laura Pavan, Quoc-Hung Le
Bulletin Du Cancer|November 17, 2004
[Acute lymphoblastic leukemia in elderly: prognosis and treatment]Xavier Thomas, Emmanuelle Tavernier, Quoc-Hung Le
Hematology (Amsterdam, Netherlands)|September 10, 2011
Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignanciesXavier Thomas, Youcef Chelghoum, Najeeb Fanari, et al.
Expert Opinion on Emerging Drugs|June 24, 2022
Antibody-based therapy for acute myeloid leukemia: a review of phase 2 and 3 trialsXavier Thomas, Mohamed Elhamri, Alexandre Deloire, et al.
Expert Opinion on Drug Discovery|March 14, 2013
The rationale and use of hypomethylation agents in adult acute myeloid leukemiaXavier Thomas, Youcef Chelghoum, Fiorenza Barraco, et al.
European Journal of Biochemistry|December 21, 2004
Escherichia coli cyclopropane fatty acid synthaseFabienne Courtois, Christine Guérard, Xavier Thomas, et al.
World Journal of Stem Cells|September 2, 2015
Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptorsMaël Heiblig, Mohamed Elhamri, Mauricette Michallet, et al.
Pageof 27

Showing results (51-60 of 262) with videos related to

Sort By:
Pageof 27
Oncology and Therapy|March 30, 2024
Is There any Relationship Between the Repeated Complications of Sickle Cell Disease and the Potential Development of Acute Leukemia?Giovanna Cannas, Mohamed Elhamri, Xavier Thomas
Bulletin Du Cancer|August 26, 2011
[Novel conventional therapies in onco-hemathology]Frédéric Baleydier, Carine Domenech, Xavier Thomas
Expert Review of Hematology|April 21, 2020
Emerging pharmacotherapies for elderly acute myeloid leukemia patientsXavier Thomas, Mohamed Elhamri, Maël Heiblig
Bulletin Du Cancer|August 30, 2008
[Adult acute lymphoblastic leukemia with central nervous system involvement: an overview]Xavier Thomas, Laura Pavan, Quoc-Hung Le
Bulletin Du Cancer|November 17, 2004
[Acute lymphoblastic leukemia in elderly: prognosis and treatment]Xavier Thomas, Emmanuelle Tavernier, Quoc-Hung Le
Hematology (Amsterdam, Netherlands)|September 10, 2011
Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignanciesXavier Thomas, Youcef Chelghoum, Najeeb Fanari, et al.
Expert Opinion on Emerging Drugs|June 24, 2022
Antibody-based therapy for acute myeloid leukemia: a review of phase 2 and 3 trialsXavier Thomas, Mohamed Elhamri, Alexandre Deloire, et al.
Expert Opinion on Drug Discovery|March 14, 2013
The rationale and use of hypomethylation agents in adult acute myeloid leukemiaXavier Thomas, Youcef Chelghoum, Fiorenza Barraco, et al.
European Journal of Biochemistry|December 21, 2004
Escherichia coli cyclopropane fatty acid synthaseFabienne Courtois, Christine Guérard, Xavier Thomas, et al.
World Journal of Stem Cells|September 2, 2015
Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptorsMaël Heiblig, Mohamed Elhamri, Mauricette Michallet, et al.
Pageof 27